ChemoGenics BioPharma Email Format
Pharmaceutical ManufacturingNorth Carolina, United States2-10 Employees
ChemoGenics BioPharma operates in the pharmaceutical manufacturing space with a focus on early-stage drug discovery and development. The company contributes to the design and synthesis of commercial and clinical candidates, offering expertise across medicinal chemistry, process optimization, scale-up, and preclinical work such as animal dosing studies, DMPK, and bioanalytical investigations in tissue and plasma. Its internal programs have progressed to human trials, including a first-in-class chemoprotective agent, with additional compounds entering clinical testing, and the organization collaborates with other companies to identify molecules for clinical development, including contributions to Trilaciclib and Lerociclib. Based in Durham, North Carolina, the firm is a small team that serves biotech and pharmaceutical clients seeking help advancing molecules toward human trials. Its focus on preclinical discovery and cross-target collaboration positions it as a specialized partner for translating promising candidates into clinical development.